FOUAD MOURSI: Open Payments
NPI 1245752021 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 20 payments from 10 companies in 2025. Trend: 2023 $334 · 2024 $482 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $134 |
| GlaxoSmithKline, LLC. | 2 | $106 |
| Exact Sciences Corporation | 4 | $97 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $95 |
| Averitas Pharma Inc. | 3 | $57 |
| Dexcom, Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: AIRSUPRA, JOURNAVX, Cologuard Collection Kit, AREXVY, QUTENZA, DEXCOM G7 GSS (161), GARDASIL 9, Dexcom G6 Transmitter.
Industry payments across FL — which companies pay providers there.
